The story of Viagra presents a challenging picture for shareholders. While the initial introduction generated significant returns, the lapse of its exclusive rights opened the floodgates to generic competitors, https://deaconzvld274015.blog2freedom.com/41907959/viagra-and-pharma-a-risky-opportunity